A pill to detect breast cancer

Print edition : May 25, 2018

Pink ribbon, a symbol of breast cancer awareness. Photo: GETTY IMAGES/ISTOCKPHOTO

SCIENTISTS have developed a pill that can make a breast cancer diagnosis that is more effective than mammograms. It makes tumours light up when exposed to infrared light.

At present, about a third of breast cancer patients treated with surgery or chemotherapy have tumours that are benign or so slow-growing that they would never have become life-threatening, researchers said. In other women, dense breast tissue hides the presence of lumps and results in deaths from treatable cancers. “If we go to molecular imaging, we can see which tumours need to be treated,” said Greg Thurber, an assistant professor at the University of Michigan who led the team.

The move could also catch cancers that would have gone undetected. Researchers used a dye that responds to infrared light to tag a molecule commonly found on tumour cells in the blood vessels that feed tumours and in inflamed tissue. By providing specific information on the types of molecules on the surface of the tumour cells, physicians can better distinguish a malignant cancer from a benign tumour.

Compared with visible light, infrared light penetrates the body easily—it can get to the depths of the breast without an X-ray’s tiny risk of disrupting DNA and seeding a new tumour. Using a dye delivered orally rather than directly into a vein also improves the safety of screening, as a few patients in 10,000 can have severe reactions to intravenous dyes.

Researchers have demonstrated that the concept works in mice. However, it is not easy to design a pill that can carry the dye to the tumour. Researchers repurposed a drug that had earlier proved to be ineffective in treating cancer and related diseases. “It’s actually based on a failed drug. It binds to the target, but it doesn’t do anything, which makes it perfect for imaging,” Thurber said. The targeting molecule has already been shown to make it through the stomach unscathed, and the liver also gives it a pass, so it can travel through the bloodstream. The team attached a molecule that fluoresces when it is struck with infrared light to this drug. Then they gave the drug to mice that had breast cancer, and they saw the tumours light up.


A letter from the Editor

Dear reader,

The COVID-19-induced lockdown and the absolute necessity for human beings to maintain a physical distance from one another in order to contain the pandemic has changed our lives in unimaginable ways. The print medium all over the world is no exception.

As the distribution of printed copies is unlikely to resume any time soon, Frontline will come to you only through the digital platform until the return of normality. The resources needed to keep up the good work that Frontline has been doing for the past 35 years and more are immense. It is a long journey indeed. Readers who have been part of this journey are our source of strength.

Subscribing to the online edition, I am confident, will make it mutually beneficial.


R. Vijaya Sankar

Editor, Frontline

Support Quality Journalism
This article is closed for comments.
Please Email the Editor